Search Results

There are 7593 results for: content related to: Plasma levels of JAK2 mRNA in patients with chronic myeloproliferative diseases with and without V617F mutation: implications for prognosis and disease biology

  1. You have free access to this content
    The JAK2V617F mutation and thrombosis

    British Journal of Haematology

    Volume 143, Issue 3, November 2008, Pages: 307–320, S. K. Austin and J. R. Lambert

    Article first published online : 30 MAY 2008, DOI: 10.1111/j.1365-2141.2008.07258.x

  2. You have free access to this content
    JAK2V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events

    American Journal of Hematology

    Volume 89, Issue 5, May 2014, Pages: 517–523, Alberto Alvarez-Larrán, Beatriz Bellosillo, Arturo Pereira, Ana Kerguelen, Juan Carlos Hernández-Boluda, Luz Martínez-Avilés, Concepción Fernández-Rodríguez, Montse Gómez, Luis Lombardía, Anna Angona, Águeda Ancochea, Alicia Senín, Raquel Longarón, Blanca Navarro, María Collado and Carlos Besses

    Article first published online : 21 FEB 2014, DOI: 10.1002/ajh.23676

  3. You have free access to this content
    JAK2 and genomic instability in the myeloproliferative neoplasms: A case of the chicken or the egg?

    American Journal of Hematology

    Volume 87, Issue 11, November 2012, Pages: 1028–1036, Linda M. Scott and Vivienne I. Rebel

    Article first published online : 28 MAY 2012, DOI: 10.1002/ajh.23243

  4. You have full text access to this Open Access content
    Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1

    Journal of Cellular and Molecular Medicine

    Volume 13, Issue 2, February 2009, Pages: 215–237, Ayalew Tefferi

    Article first published online : 23 OCT 2008, DOI: 10.1111/j.1582-4934.2008.00559.x

  5. You have free access to this content
    The JAK2 exon 12 mutations: A comprehensive review

    American Journal of Hematology

    Volume 86, Issue 8, August 2011, Pages: 668–676, Linda M. Scott

    Article first published online : 14 JUN 2011, DOI: 10.1002/ajh.22063

  6. You have free access to this content
    JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation

    British Journal of Haematology

    Volume 150, Issue 3, August 2010, Pages: 334–344, Seido Oku, Katsuto Takenaka, Takuro Kuriyama, Kotaro Shide, Takashi Kumano, Yoshikane Kikushige, Shingo Urata, Takuji Yamauchi, Chika Iwamoto, Haruko K. Shimoda, Toshihiro Miyamoto, Koji Nagafuji, Junji Kishimoto, Kazuya Shimoda and Koichi Akashi

    Article first published online : 10 JUN 2010, DOI: 10.1111/j.1365-2141.2010.08249.x

  7. Hematopoietic clonal dominance, stem cell mutations, and evolutionary pattern of JAK2V617F allele burden in polycythemia vera

    European Journal of Haematology

    Volume 94, Issue 3, March 2015, Pages: 251–257, Anna Angona, Alberto Alvarez-Larrán, Beatriz Bellosillo, Luz Martínez-Avilés, Laura Camacho, Concepción Fernández-Rodríguez, Silvia Pairet, Raquel Longarón, Águeda Ancochea, Alicia Senín, Lourdes Florensa and Carles Besses

    Article first published online : 13 SEP 2014, DOI: 10.1111/ejh.12425

  8. You have free access to this content
    The role of serum erythropoietin level and jak2 v617f allele burden in the diagnosis of polycythaemia vera

    British Journal of Haematology

    Volume 167, Issue 3, November 2014, Pages: 411–417, Àgueda Ancochea, Alberto Álvarez-Larrán, Cristian Morales-Indiano, Francesc García-Pallarols, Luz Martínez-Avilés, Anna Angona, Alicia Senín, Beatriz Bellosillo and Carles Besses

    Article first published online : 18 JUL 2014, DOI: 10.1111/bjh.13047

  9. Chromosome 9p24 abnormalities: prevalence, description of novel JAK2 translocations, JAK2V617F mutation analysis and clinicopathologic correlates

    European Journal of Haematology

    Volume 84, Issue 6, June 2010, Pages: 518–524, Mrinal M. Patnaik, Ryan A. Knudson, Naseema Gangat, Curtis A. Hanson, Animesh Pardanani, Ayalew Tefferi and Rhett P. Ketterling

    Article first published online : 11 MAR 2010, DOI: 10.1111/j.1600-0609.2010.01428.x

  10. You have free access to this content
    Experimental therapeutics for patients with myeloproliferative neoplasias

    Cancer

    Volume 117, Issue 4, 15 February 2011, Pages: 662–676, Meetu Agrawal, Ravin J. Garg, Jorge Cortes, Hagop Kantarjian, Srdan Verstovsek and Alfonso Quintas-Cardama

    Article first published online : 4 OCT 2010, DOI: 10.1002/cncr.25672

  11. You have free access to this content
    Molecular diagnostics of myeloproliferative neoplasms

    European Journal of Haematology

    Volume 95, Issue 4, October 2015, Pages: 270–279, Stephen E. Langabeer, Hajnalka Andrikovics, Julia Asp, Beatriz Bellosillo, Serge Carillo, Karl Haslam, Lasse Kjaer, Eric Lippert, Olivier Mansier, Elisabeth Oppliger Leibundgut, Melanie J. Percy, Naomi Porret, Lars Palmqvist, Jiri Schwarz, Mary F. McMullin, Susanne Schnittger, Niels Pallisgaard, Sylvie Hermouet and on behalf of the MPN&MPNr-EuroNet

    Article first published online : 18 MAY 2015, DOI: 10.1111/ejh.12578

  12. Application of mutant JAK2V617F for in vitro generation of red blood cells

    Transfusion

    Sun Ah Lee, Ji Yeon Kim, Yongwook Choi, Yonggoo Kim and Hyun Ok Kim

    Article first published online : 9 DEC 2015, DOI: 10.1111/trf.13431

  13. Frequency and clinical features of the JAK2 V617F mutation in pediatric patients with sporadic essential thrombocythemia

    Pediatric Blood & Cancer

    Volume 51, Issue 6, December 2008, Pages: 802–805, Takuya Nakatani, Toshihiko Imamura, Hiroyuki Ishida, Katsuji Wakaizumi, Tohru Yamamoto, Osamu Otabe, Tsuyoshi Ishigami, Souichi Adachi and Akira Morimoto

    Article first published online : 18 SEP 2008, DOI: 10.1002/pbc.21730

  14. You have free access to this content
    Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations

    British Journal of Haematology

    Volume 160, Issue 1, January 2013, Pages: 25–34, Anthony J. Bench, Helen E. White, Letizia Foroni, Anna L. Godfrey, Gareth Gerrard, Susanna Akiki, Abida Awan, Ian Carter, Andrea Goday-Fernandez, Stephen E. Langabeer, Tim Clench, Jordan Clark, Paul A. Evans, David Grimwade, Anna Schuh, Mary F. McMullin, Anthony R. Green, Claire N. Harrison and Nicholas C. P. Cross

    Article first published online : 11 OCT 2012, DOI: 10.1111/bjh.12075

  15. JAK2V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status

    European Journal of Haematology

    Volume 77, Issue 3, September 2006, Pages: 210–216, Paula G. Heller, Paola R. Lev, Juan P. Salim, Laura I. Kornblihtt, Nora P. Goette, Carlos D. Chazarreta, Ana C. Glembotsky, Patricia S. Vassallu, Rosana F. Marta and Felisa C. Molinas

    Article first published online : 17 MAY 2006, DOI: 10.1111/j.1600-0609.2006.00688.x

  16. You have free access to this content
    JAK2-V617F mutation analysis of granulocytes and platelets from patients with chronic myeloproliferative disorders: advantage of studying platelets

    British Journal of Haematology

    Volume 139, Issue 1, October 2007, Pages: 64–69, Kohtaro Toyama, Masamitsu Karasawa, Arito Yamane, Hiroyuki Irisawa, Akihiko Yokohama, Takayuki Saitoh, Hiroshi Handa, Takafumi Matsushima, Morio Sawamura, Shuichi Miyawaki, Hirokazu Murakami, Yoshihisa Nojima and Norifumi Tsukamoto

    Article first published online : 11 SEP 2007, DOI: 10.1111/j.1365-2141.2007.06755.x

  17. You have free access to this content
    Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms

    British Journal of Haematology

    Volume 147, Issue 4, November 2009, Pages: 495–506, Lizz F. Grimwade, Lisa Happerfield, Colin Tristram, Gary McIntosh, Mark Rees, Anthony J. Bench, Elaine M. Boyd, Marie Hall, Amy Quinn, Nigel Piggott, Paul Scorer, Mike A. Scott and Wendy N. Erber

    Article first published online : 31 AUG 2009, DOI: 10.1111/j.1365-2141.2009.07870.x

  18. JAK2 46/1 haplotype is associated with JAK2 V617F – positive myeloproliferative neoplasms in Brazilian patients

    International Journal of Laboratory Hematology

    Volume 37, Issue 5, October 2015, Pages: 654–660, L. C. Macedo, B. C. Santos, S. Pagliarini-e-Silva, K. B. B. Pagnano, C. Rodrigues, F. C. Quintero, M. E. Ferreira, E. C. Baraldi, E. P. Ambrosio-Albuquerque, A. M. Sell and J. E. L. Visentainer

    Article first published online : 11 MAY 2015, DOI: 10.1111/ijlh.12380

  19. Mutations profile of polycythemia vera and essential thrombocythemia among Japanese children

    Pediatric Blood & Cancer

    Volume 59, Issue 3, September 2012, Pages: 530–535, Olfat Ismael, Akira Shimada, Asahito Hama, Hiroshi Sakaguchi, Sayoko Doisaki, Hideki Muramatsu, Nao Yoshida, Masafumi Ito, Yoshiyuki Takahashi, Naohiro Akita, Shosuke Sunami, Yoshitoshi Ohtsuka, Youji Asada, Hiroyuki Fujisaki and Seiji Kojima

    Article first published online : 21 NOV 2011, DOI: 10.1002/pbc.23409

  20. You have free access to this content
    Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population

    British Journal of Haematology

    Volume 160, Issue 1, January 2013, Pages: 70–79, Camilla Nielsen, Henrik S. Birgens, Børge G. Nordestgaard and Stig E. Bojesen

    Article first published online : 1 NOV 2012, DOI: 10.1111/bjh.12099